Zobrazeno 1 - 6
of 6
pro vyhledávání: '"G Nieuwenhuyzen-de Boer"'
Autor:
A Bijleveld, Suwasin Udomkarnjananun, H. J. van Beekhuizen, G Nieuwenhuyzen-de Boer, M Kengsakul, Christa D. Niehot, Stephen J. Kerr
Publikováno v:
E-Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66c37390453877aa0351dfcd074a82dc
https://doi.org/10.1136/ijgc-2021-igcs.280
https://doi.org/10.1136/ijgc-2021-igcs.280
Autor:
C Niehot, M Kengsakul, Suwasin Udomkarnjananun, G Nieuwenhuyzen-de Boer, A Bijleveld, Stephen J. Kerr, HJ Van Beekhuizen
Publikováno v:
Ovarian cancer.
Introduction/Background* Favourable survival outcomes for patients with advanced stage ovarian cancer are associated with complete cytoreduction. In this study, we evaluated the survival impact of cardiophrenic lymph node enlargement in women with ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e6549085774ee63ba71467321a22411
https://doi.org/10.1136/ijgc-2021-esgo.493
https://doi.org/10.1136/ijgc-2021-esgo.493
Publikováno v:
Ovarian cancer.
Introduction/Background* The aim of surgery for advanced-stage ovarian cancer is complete cytoreductive surgery, because this is the most important independent prognostic factor for prolonged survival. Yet this can be difficult to achieve when there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c74a8c262e6d271a374e26744980d1ea
https://doi.org/10.1136/ijgc-2021-esgo.354
https://doi.org/10.1136/ijgc-2021-esgo.354
Autor:
G Nieuwenhuyzen-de Boer, S Willemsen, HJ Van Beekhuizen, PC Ewing-Graham, Astrid Baalbergen, IG Schoots, IA Boere, AMLDVan Haaften-de Jong, N. Reesink-Peters, I Nedelcu, J.J. Beltman, L. Hofman, Hmj Werner, L. Haans, M. Dorman, W. Hofhuis, W.J. van Driel, J Piek
Publikováno v:
Ovarian cancer.
Results of the PlaComOv-study, a randomized, controlled trial in the Netherlands Introduction/Background* The most important prognostic factor for patients with advanced-stage ovarian cancer is complete cytoreductive surgery (CRS). Standard surgical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e5771cc22ca21b9488cfe2f65f8664e
https://doi.org/10.1136/ijgc-2021-esgo.375
https://doi.org/10.1136/ijgc-2021-esgo.375
Autor:
G Nieuwenhuyzen – de Boer, Rogier L. Goetgebuer, Joany E. Kreijne, Marie J. Pierik, N. K. H. de Boer, Frank Hoentjen, F. J. van Kemenade, Gerard Dijkstra, Albert G. Siebers, C.J. van der Woude, Clare A. Aitken, A C de Vries, Cyriel I J Ponsioen, A. van der Meulen, Bas Oldenburg
Publikováno v:
Journal of Crohn's and Colitis. 13:S513-S513
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f2e79db58efe55b20ba76d0c0ffbb60
https://doi.org/10.1093/ecco-jcc/jjy222.908
https://doi.org/10.1093/ecco-jcc/jjy222.908
Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer
Publikováno v:
European Journal of Cancer, 46(1), 102-109. Elsevier Ltd.
Objective: Treatment in advanced stage epithelial ovarian cancer (EOC) is based on primary cytoreductive surgery followed by platinum-based chemotherapy Successful cytoreduction to minimal residual tumour burden is the most important determinant of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291b7a1d9a51d6e8c88aadb7f49f5309
https://hdl.handle.net/1765/28155
https://hdl.handle.net/1765/28155